These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13910377)

  • 1. Investigation of the serum properdin levels in neoplastic diseases determined by the bacteriophage neutralization assay.
    SEKIGUCHI M; ASHIKAWA K; MOTOYA K; ISHIBASHI Y
    Gan; 1962 Jun; 53():129-43. PubMed ID: 13910377
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDIES ON HOST DEFENSES AGAINST CANCER. 1. ON THE BACTERIOPHAGE NEUTRALIZING ACTIVITY OF SERUMS].
    SEKIGUCHI M
    Arerugi; 1963; 12():348-57. PubMed ID: 14095328
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
    [No Abstract]   [Full Text] [Related]  

  • 6. The properdin system and immunity. XII. Assay, properties and partial purification of a hydrazine-sensitive serum factor (factor A) in the properdin system.
    PENSKY J; WURZ L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():329-48. PubMed ID: 14431638
    [No Abstract]   [Full Text] [Related]  

  • 7. The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():349-57. PubMed ID: 13801696
    [No Abstract]   [Full Text] [Related]  

  • 8. [The properdin level in neoplasms and in malignant blood diseases].
    DIOMEDE-FRESA V; FUMAROLA A
    Prog Med (Napoli); 1959 May; 15():310-4. PubMed ID: 13816890
    [No Abstract]   [Full Text] [Related]  

  • 9. Interpretation of properdin levels determined by phage neutralization technique.
    COWAN KM
    Science; 1958 Oct; 128(3327):778-9. PubMed ID: 13592254
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of properdin in the first days of life. Study by bacteriophage neutralization].
    CONCA G
    Minerva Pediatr; 1959 Sep; 11():992-6. PubMed ID: 13811458
    [No Abstract]   [Full Text] [Related]  

  • 11. RETICULOENDOTHELIAL SYSTEM AND NEOPLASMA.
    ISHIBASHI Y
    Tohoku J Exp Med; 1964 Feb; 82():42-7. PubMed ID: 14136091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on the determination of properdin by means of bacteriophage neutralization].
    PERNIS B; TURRI M
    Boll Ist Sieroter Milan; 1958; 37(9-10):414-24. PubMed ID: 13607654
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of the serum properdin level in neoplasms of the uterus].
    D'ANTONA N
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1382-4. PubMed ID: 13813591
    [No Abstract]   [Full Text] [Related]  

  • 14. [On properdin determination in the serum of rats with rapidly growing inoculation tumors].
    KALLENBACH H; THUERIGEN G
    Z Gesamte Exp Med; 1960; 133():304-9. PubMed ID: 13750946
    [No Abstract]   [Full Text] [Related]  

  • 15. [The properdin system. Part 1. A modified method for determination of properdin in the serum].
    MAASSEN W
    Z Immun exp ther; 1960 May; 119():405-14. PubMed ID: 14419242
    [No Abstract]   [Full Text] [Related]  

  • 16. [Variations of properdin in cancer patients].
    MARQUES P; DOUSTE-BLAZY L; LLOVERAS J; PUEL J
    Bull Assoc Fr Etud Cancer; 1960; 47():479-87. PubMed ID: 13767080
    [No Abstract]   [Full Text] [Related]  

  • 17. [Natural immunity and malignant uterine neoplasms].
    DE CECCO L
    Quad Clin Ostet Ginecol; 1961 Oct; 16():726-40. PubMed ID: 13884167
    [No Abstract]   [Full Text] [Related]  

  • 18. [The properdin system in normal and pathological tissue].
    MARQUES P; DOUSTE-BLAZY L; PUEL J
    Bull Assoc Fr Etud Cancer; 1962; 49():84-93. PubMed ID: 14470153
    [No Abstract]   [Full Text] [Related]  

  • 19. [The inhibitory activity of serum against T2r + bacteriophage in relation to properdin].
    FRANCQ JC; EYQUEM A; GUYOTJEANNIN N
    Ann Inst Pasteur (Paris); 1959 Feb; 96(2):178-83. PubMed ID: 13627583
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the determination of so-called "available properdin" in human serum].
    von GRAEVENITZ
    Arztl Forsch; 1960 Mar; 14():I/134-6. PubMed ID: 13855870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.